- Home
- JXG vs WGRX Comparison
JXG vs WGRX Comparison
Compare JXG & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JXG | WGRX |
|---|---|---|
| Founded | N/A | 2022 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JXG | WGRX |
|---|---|---|
| Price | $8.20 | $3.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.9K | ★ 46.5M |
| Earning Date | 05-14-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.07 |
| 52 Week High | $10.29 | $4.25 |
Technical Indicators
Market Signals| Indicator | JXG | WGRX |
|---|---|---|
| Relative Strength Index (RSI) | 78.62 | 80.28 |
| Support Level | $3.57 | $0.29 |
| Resistance Level | $10.29 | N/A |
| Average True Range (ATR) | 0.73 | 0.23 |
| MACD | 0.27 | 0.42 |
| Stochastic Oscillator | 89.77 | 82.06 |
Price Performance
Historical ComparisonAbout JXG JX Luxventure Limited
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About WGRX Wellgistics Health Inc.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.